Paul F. Truex
Net Worth

Last updated:

What is Paul F. Truex net worth?

The estimated net worth of Mr. Paul F. Truex is at least $3,069,867 as of 7 Sep 2017. He owns shares worth $2 as insider, has earned $1,269,865 from insider trading and has received compensation worth at least $1,800,000 in Anthera Pharmaceuticals, Inc..

What is the salary of Paul F. Truex?

Mr. Paul F. Truex salary is $100,000 per year as Executive Chairman in Anthera Pharmaceuticals, Inc..

How old is Paul F. Truex?

Mr. Paul F. Truex is 56 years old, born in 1969.

What stocks does Paul F. Truex currently own?

As insider, Mr. Paul F. Truex owns shares in one company:

Company Title Shares Price per share Total value
Anthera Pharmaceuticals, Inc. (ANTH) Executive Chairman 16,793 $0 $2

What does Anthera Pharmaceuticals, Inc. do?

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.

ANTH logo
ANTH
Anthera Pharmaceuticals, Inc.
$0

Paul F. Truex insider trading

Anthera Pharmaceuticals, Inc.

Mr. Paul F. Truex has made 10 insider trades between 2007-2017, according to the Form 4 filled with the SEC. Most recently he purchased 5,000 units of ANTH stock worth $6,700 on 7 Sep 2017.

The largest trade he's ever made was exercising 50,000 units of ANTH stock on 8 Aug 2011. As of 7 Sep 2017 he still owns at least 16,793 units of ANTH stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 5,000 $1.34 $6,700
Option
Common stock 5,008 $2.08 $10,417
Option
Common Stock 2,000 $2.08 $4,160
Purchase
Common stock 20,000 $0.76 $15,200
Sale
Common stock 15,000 $7.84 $117,600
Option
Common stock 20,000 $0.26 $5,200
Sale
Common stock 15,000 $6.75 $101,250
Sale
Common stock 15,000 $6.34 $95,070
Sale
Common Stock 30,000 $6.96 $208,710
Sale
Common Stock 30,000 $6.96 $208,710
Sale
Common Stock 23,235 $6.25 $145,219
Sale
Common Stock 6,745 $6.25 $42,156
Option
Stock Option (right to buy) 50,000 $0.26 $13,000
Option
Common Stock 50,000 $0.26 $13,000
Sale
Common Stock 15,000 $7.95 $119,265
Sale
Common Stock 15,000 $8.3 $124,545
Sale
Common Stock 15,000 $7.16 $107,340
Option
Stock Option (right to buy) 30,000 $0.26 $7,800
Option
Common Stock 30,000 $0.26 $7,800
Option
Stock Option (right to buy) 20,000 $0.26 $5,200
Option
Common Stock 23,364 $0.14 $3,271
Option
Stock Option (right to buy) 23,364 $0.14 $3,271
Purchase
Common Stock 1,000 $7.14 $7,140
Option
Stock Option (right to buy) 5,008 $2.08 $10,417

Anthera Pharmaceuticals key executives

Anthera Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: